J&J Harnessing Pharma Business Advantages For Global OTC Growth
This article was originally published in The Tan Sheet
Executive Summary
Johnson & Johnson's consumer products division is leveraging the capabilities of its prescription pharmaceutical business infrastructures to grow its "iconic brands" and create new products